Cargando…

Association between uric acid lowering and renal function progression: a longitudinal study

BACKGROUND: This study aimed to explore the association between uric acid lowering and renal function. MATERIALS AND METHODS: We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liyi, You, Lili, Sun, Kan, Li, Feng, Qi, Yiqin, Chen, Chaogang, Wang, Chuan, Lao, Guojuan, Xue, Shengneng, Tang, Juying, Li, Na, Feng, Wanting, Yang, Chuan, Xu, Mingtong, Li, Yan, Yan, Li, Ren, Meng, Lin, Diaozhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000451/
https://www.ncbi.nlm.nih.gov/pubmed/33828916
http://dx.doi.org/10.7717/peerj.11073
_version_ 1783671002831519744
author Liu, Liyi
You, Lili
Sun, Kan
Li, Feng
Qi, Yiqin
Chen, Chaogang
Wang, Chuan
Lao, Guojuan
Xue, Shengneng
Tang, Juying
Li, Na
Feng, Wanting
Yang, Chuan
Xu, Mingtong
Li, Yan
Yan, Li
Ren, Meng
Lin, Diaozhu
author_facet Liu, Liyi
You, Lili
Sun, Kan
Li, Feng
Qi, Yiqin
Chen, Chaogang
Wang, Chuan
Lao, Guojuan
Xue, Shengneng
Tang, Juying
Li, Na
Feng, Wanting
Yang, Chuan
Xu, Mingtong
Li, Yan
Yan, Li
Ren, Meng
Lin, Diaozhu
author_sort Liu, Liyi
collection PubMed
description BACKGROUND: This study aimed to explore the association between uric acid lowering and renal function. MATERIALS AND METHODS: We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range of changes in serum uric acid with quartile 1 representing lower quarter. Renal function decline was defined as eGFR decreased more than 10% from baseline in 2016. Renal function improvement was defined as eGFR increased more than 10% from baseline in 2016. Cox regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: In the adjusted Cox regression models, compared to quartile 4, quartile 1 (HR = 0.64, 95% CI [0.49–0.85]), quartile 2 (HR = 0.65, 95% CI [0.50–0.84]) and quartile 3 (HR = 0.75, 95% CI [0.58–0.96]) have reduced risk of renal function decline. An increasing hazard ratio of renal function improvement was shown in quartile 1 (HR = 2.27, 95% CI [1.45–3.57]) and quartile 2 (HR = 1.78, 95% CI [1.17–2.69]) compared with quartile 4. CONCLUSIONS: Uric acid lowering is associated with changes in renal function. The management of serum uric acid should receive attention in clinical practice and is supposed to be part of the treatment of chronic kidney disease.
format Online
Article
Text
id pubmed-8000451
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-80004512021-04-06 Association between uric acid lowering and renal function progression: a longitudinal study Liu, Liyi You, Lili Sun, Kan Li, Feng Qi, Yiqin Chen, Chaogang Wang, Chuan Lao, Guojuan Xue, Shengneng Tang, Juying Li, Na Feng, Wanting Yang, Chuan Xu, Mingtong Li, Yan Yan, Li Ren, Meng Lin, Diaozhu PeerJ Diabetes and Endocrinology BACKGROUND: This study aimed to explore the association between uric acid lowering and renal function. MATERIALS AND METHODS: We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range of changes in serum uric acid with quartile 1 representing lower quarter. Renal function decline was defined as eGFR decreased more than 10% from baseline in 2016. Renal function improvement was defined as eGFR increased more than 10% from baseline in 2016. Cox regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: In the adjusted Cox regression models, compared to quartile 4, quartile 1 (HR = 0.64, 95% CI [0.49–0.85]), quartile 2 (HR = 0.65, 95% CI [0.50–0.84]) and quartile 3 (HR = 0.75, 95% CI [0.58–0.96]) have reduced risk of renal function decline. An increasing hazard ratio of renal function improvement was shown in quartile 1 (HR = 2.27, 95% CI [1.45–3.57]) and quartile 2 (HR = 1.78, 95% CI [1.17–2.69]) compared with quartile 4. CONCLUSIONS: Uric acid lowering is associated with changes in renal function. The management of serum uric acid should receive attention in clinical practice and is supposed to be part of the treatment of chronic kidney disease. PeerJ Inc. 2021-03-24 /pmc/articles/PMC8000451/ /pubmed/33828916 http://dx.doi.org/10.7717/peerj.11073 Text en ©2021 Liu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Diabetes and Endocrinology
Liu, Liyi
You, Lili
Sun, Kan
Li, Feng
Qi, Yiqin
Chen, Chaogang
Wang, Chuan
Lao, Guojuan
Xue, Shengneng
Tang, Juying
Li, Na
Feng, Wanting
Yang, Chuan
Xu, Mingtong
Li, Yan
Yan, Li
Ren, Meng
Lin, Diaozhu
Association between uric acid lowering and renal function progression: a longitudinal study
title Association between uric acid lowering and renal function progression: a longitudinal study
title_full Association between uric acid lowering and renal function progression: a longitudinal study
title_fullStr Association between uric acid lowering and renal function progression: a longitudinal study
title_full_unstemmed Association between uric acid lowering and renal function progression: a longitudinal study
title_short Association between uric acid lowering and renal function progression: a longitudinal study
title_sort association between uric acid lowering and renal function progression: a longitudinal study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000451/
https://www.ncbi.nlm.nih.gov/pubmed/33828916
http://dx.doi.org/10.7717/peerj.11073
work_keys_str_mv AT liuliyi associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT youlili associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT sunkan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT lifeng associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT qiyiqin associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT chenchaogang associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT wangchuan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT laoguojuan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT xueshengneng associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT tangjuying associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT lina associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT fengwanting associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT yangchuan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT xumingtong associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT liyan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT yanli associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT renmeng associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT lindiaozhu associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy